Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the most up-to-date technologies related to the field of clinical chemistry. Chapters in this new release cover Advances in immunosensor technology, Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury, Oxidative stress biomarkers in the preterm infant, Translational biomarkers in the era of precision medicine, Metabolomics applications in coronary artery disease personalized medicine, Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Contributors - p. page_vii 6. Preface - p. page_ix 7. Chapter One: Advances in immunosensor technology - p. page_1 8. Chapter Two: Extracellular vesicles: Roles and applications in drug-induced liver injury - p. page_63 9. Chapter Three: Oxidative stress biomarkers in the preterm infant - p. page_127 10. Chapter Four: Translational biomarkers in the era of precision medicine - p. page_191 11. Chapter Five: Metabolomics applications in coronary artery disease personalized medicine - p. page_233 12. Chapter Six: Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers - p. page_271 13. Index - p. page_337
Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the most up-to-date technologies related to the field of clinical chemistry. Chapters in this new release cover Advances in immunosensor technology, Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury, Oxidative stress biomarkers in the preterm infant, Translational biomarkers in the era of precision medicine, Metabolomics applications in coronary artery disease personalized medicine, Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Contributors - p. page_vii 6. Preface - p. page_ix 7. Chapter One: Advances in immunosensor technology - p. page_1 8. Chapter Two: Extracellular vesicles: Roles and applications in drug-induced liver injury - p. page_63 9. Chapter Three: Oxidative stress biomarkers in the preterm infant - p. page_127 10. Chapter Four: Translational biomarkers in the era of precision medicine - p. page_191 11. Chapter Five: Metabolomics applications in coronary artery disease personalized medicine - p. page_233 12. Chapter Six: Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers - p. page_271 13. Index - p. page_337
